Guardian Pharmacy Services (GRDN) Competitors $20.53 +0.14 (+0.69%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends GRDN vs. PETS, YI, CJJD, CVS, WBA, INSP, NUVL, TEM, GRFS, and RDNTShould you be buying Guardian Pharmacy Services stock or one of its competitors? The main competitors of Guardian Pharmacy Services include PetMed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), CVS Health (CVS), Walgreens Boots Alliance (WBA), Inspire Medical Systems (INSP), Nuvalent (NUVL), Tempus AI (TEM), Grifols (GRFS), and RadNet (RDNT). Guardian Pharmacy Services vs. PetMed Express 111 China Jo-Jo Drugstores CVS Health Walgreens Boots Alliance Inspire Medical Systems Nuvalent Tempus AI Grifols RadNet Guardian Pharmacy Services (NYSE:GRDN) and PetMed Express (NASDAQ:PETS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment, community ranking and analyst recommendations. Does the media favor GRDN or PETS? In the previous week, PetMed Express' average media sentiment score of 1.11 beat Guardian Pharmacy Services' score of 0.00 indicating that PetMed Express is being referred to more favorably in the news media. Company Overall Sentiment Guardian Pharmacy Services Neutral PetMed Express Positive Which has preferable valuation and earnings, GRDN or PETS? Guardian Pharmacy Services has higher earnings, but lower revenue than PetMed Express. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardian Pharmacy ServicesN/AN/AN/AN/AN/APetMed Express$281.06M0.38-$7.46M-$0.06-85.17 Do institutionals & insiders have more ownership in GRDN or PETS? 73.3% of PetMed Express shares are held by institutional investors. 1.1% of PetMed Express shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in GRDN or PETS? PetMed Express received 211 more outperform votes than Guardian Pharmacy Services when rated by MarketBeat users. However, 100.00% of users gave Guardian Pharmacy Services an outperform vote while only 45.17% of users gave PetMed Express an outperform vote. CompanyUnderperformOutperformGuardian Pharmacy ServicesOutperform Votes4100.00% Underperform VotesNo VotesPetMed ExpressOutperform Votes21545.17% Underperform Votes26154.83% Do analysts rate GRDN or PETS? Guardian Pharmacy Services currently has a consensus target price of $22.00, indicating a potential upside of 7.16%. PetMed Express has a consensus target price of $3.50, indicating a potential downside of 31.51%. Given Guardian Pharmacy Services' stronger consensus rating and higher probable upside, analysts plainly believe Guardian Pharmacy Services is more favorable than PetMed Express.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardian Pharmacy Services 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00PetMed Express 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Is GRDN or PETS more profitable? Guardian Pharmacy Services has a net margin of 0.00% compared to PetMed Express' net margin of -0.37%. Guardian Pharmacy Services' return on equity of 0.00% beat PetMed Express' return on equity.Company Net Margins Return on Equity Return on Assets Guardian Pharmacy ServicesN/A N/A N/A PetMed Express -0.37%-1.00%-0.60% SummaryGuardian Pharmacy Services beats PetMed Express on 7 of the 12 factors compared between the two stocks. Get Guardian Pharmacy Services News Delivered to You Automatically Sign up to receive the latest news and ratings for GRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRDN vs. The Competition Export to ExcelMetricGuardian Pharmacy ServicesDrug stores & proprietary stores IndustryMedical SectorNYSE ExchangeMarket Cap$1.27B$7.20B$5.20B$19.26BDividend YieldN/A7.02%5.13%3.72%P/E RatioN/A2.6889.8041.43Price / SalesN/A0.181,246.2617.05Price / CashN/A71.7643.8219.84Price / BookN/A0.855.325.76Net IncomeN/A-$46.88M$122.69M$993.25M7 Day Performance3.58%0.24%-0.17%3.26%1 Month Performance-6.00%0.94%3.49%5.71%1 Year PerformanceN/A-41.76%25.79%18.85% Guardian Pharmacy Services Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRDNGuardian Pharmacy Services0.2604 of 5 stars$20.53+0.7%$22.00+7.2%N/A$1.27BN/A0.003,200PETSPetMed Express0.4425 of 5 stars$4.85+1.7%$3.50-27.8%-25.3%$100.22M$259.34M-80.83210Positive NewsYI1110.3021 of 5 stars$0.44-10.4%N/A-70.9%$37.72M$14.66B-1.101,520Stock SplitShort Interest ↑News CoverageCJJDChina Jo-Jo DrugstoresN/A$1.97-0.5%N/A-53.2%$13.11M$154.54M0.00980Analyst ForecastShort Interest ↓News CoveragePositive NewsGap UpCVSCVS Health5 of 5 stars$51.54+7.4%$68.71+33.3%-28.6%$64.86B$368.91B13.08300,000News CoverageWBAWalgreens Boots Alliance3.689 of 5 stars$11.90+1.2%$12.81+7.6%-43.5%$10.28B$147.66B-1.19312,000Earnings ReportAnalyst ForecastShort Interest ↓News CoverageINSPInspire Medical Systems4.8705 of 5 stars$175.75-13.2%$233.58+32.9%-8.0%$5.27B$755.59M164.251,011Gap DownHigh Trading VolumeNUVLNuvalent1.9771 of 5 stars$72.09-5.9%$112.36+55.9%+3.2%$5.12BN/A-20.7840Analyst ForecastInsider TradeNews CoverageTEMTempus AI3.0662 of 5 stars$32.34-13.8%$56.00+73.2%N/A$5.09B$640.44M0.002,300Analyst ForecastInsider TradeShort Interest ↑Gap DownGRFSGrifols3.0807 of 5 stars$7.23-0.8%N/A+7.7%$4.97B$7.01B5.9326,300Positive NewsGap DownRDNTRadNet4.2762 of 5 stars$66.59-3.2%$84.75+27.3%+60.4%$4.93B$1.77B-951.158,970Analyst ForecastNews CoveragePositive NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies PetMed Express Alternatives 111 Alternatives China Jo-Jo Drugstores Alternatives CVS Health Alternatives Walgreens Boots Alliance Alternatives Inspire Medical Systems Alternatives Nuvalent Alternatives Tempus AI Alternatives Grifols Alternatives RadNet Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:GRDN) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRDN Stock Alerts